Cargando…
8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma
BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS:...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667367/ https://www.ncbi.nlm.nih.gov/pubmed/34895169 http://dx.doi.org/10.1186/s12876-021-02057-0 |
_version_ | 1784614376269938688 |
---|---|
author | Cai, Congbo Yang, Lei Zhou, Kena |
author_facet | Cai, Congbo Yang, Lei Zhou, Kena |
author_sort | Cai, Congbo |
collection | PubMed |
description | BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS: We screened out 3 hypoxia genes (ENO1, UGP2, TPI1) to make the model, which can predict prognosis in HCC. And this model emerges as an independent prognostic factor for HCC. A Nomogram was drawn to evaluate the overall survival in a more accurate way. Furthermore, immune infiltration state and immunosuppressive microenvironment of the tumor were detected in high-risk patients. CONCLUSION: We establish and validate a risk prognostic model developed by 3 hypoxia genes, which could effectively evaluate the prognosis of HCC patients. This prognostic model can be used as a guidance for hypoxia modification in HCC patients undergoing immunotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-02057-0. |
format | Online Article Text |
id | pubmed-8667367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86673672021-12-13 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma Cai, Congbo Yang, Lei Zhou, Kena BMC Gastroenterol Research BACKGROUND: Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma (HCC) by changing the tumor microenvironment. Until now the association between hypoxia genes and prognosis of HCC remains obscure. We attempt to construct a hypoxia model to predict the prognosis in HCC. RESULTS: We screened out 3 hypoxia genes (ENO1, UGP2, TPI1) to make the model, which can predict prognosis in HCC. And this model emerges as an independent prognostic factor for HCC. A Nomogram was drawn to evaluate the overall survival in a more accurate way. Furthermore, immune infiltration state and immunosuppressive microenvironment of the tumor were detected in high-risk patients. CONCLUSION: We establish and validate a risk prognostic model developed by 3 hypoxia genes, which could effectively evaluate the prognosis of HCC patients. This prognostic model can be used as a guidance for hypoxia modification in HCC patients undergoing immunotherapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-021-02057-0. BioMed Central 2021-12-12 /pmc/articles/PMC8667367/ /pubmed/34895169 http://dx.doi.org/10.1186/s12876-021-02057-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cai, Congbo Yang, Lei Zhou, Kena 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title | 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title_full | 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title_fullStr | 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title_full_unstemmed | 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title_short | 8DEstablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
title_sort | 8destablishment and validation of a hypoxia-related signature predicting prognosis in hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667367/ https://www.ncbi.nlm.nih.gov/pubmed/34895169 http://dx.doi.org/10.1186/s12876-021-02057-0 |
work_keys_str_mv | AT caicongbo 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma AT yanglei 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma AT zhoukena 8destablishmentandvalidationofahypoxiarelatedsignaturepredictingprognosisinhepatocellularcarcinoma |